Tranexamic acid (TXA) is a synthetic molecule derived from the amino acid lysine. TXA is a pro-coagulant that produces antifibrinolytic effects by reversibly blocking the sites where lysine binds to plasminogen, slowing down plasminogen’s clot-dissolving activity.
Epsilon-aminocaproic acid (EACA) is a related compound with antifibrinolytic activity but …



